Art

J-GLOBAL ID：202002273447881486   Reference number：20A1623443

Monitoring the roles of prothrombin activation fragment 1 and 2 (F1 + 2) in patients with atrial fibrillation receiving rivaroxaban and apixaban

リバロキサバンおよびアピキサバン投与心房細動患者におけるプロトロンビン活性化フラグメント1および2(F1+2)の役割のモニタリング【JST・京大機械翻訳】

Author (10)： Ueno Ei-ichi (Department of Cardiology, Kanazawa Medical University, Uchinada, Japan) ,  Fujibayashi Kosuke (Department of Cardiology, Kanazawa Medical University, Uchinada, Japan) ,  Sawaguchi Jun (Department of Cardiology, Kanazawa Medical University, Uchinada, Japan) ,  Yasuda Yushi (Department of Cardiology, Kanazawa Medical University, Uchinada, Japan) ,  Takano Shintaro (Department of Cardiology, Kanazawa Medical University, Uchinada, Japan) ,  Fujioka Nakaba (Department of Cardiology, Kanazawa Medical University, Uchinada, Japan) ,  Kawai Yasuyuki (Department of Cardiology, Kanazawa Medical University, Uchinada, Japan) ,  Fujita Harumi (Central Clinical Laboratoy, Kanazawa Medical University Hospital, Uchinada, Japan) ,  Tanaka Yoshi (Central Clinical Laboratoy, Kanazawa Medical University Hospital, Uchinada, Japan) ,  Kajinami Kouji (Department of Cardiology, Kanazawa Medical University, Uchinada, Japan)
Material： Journal of Thrombosis and Thrombolysis
Volume： 50  Issue： 2  Page： 371-379  Publication year： 2020 
JST Material Number： W4673A  ISSN： 0929-5305  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Abstract/Point： Abstract: Factor Xa (FXa) inhi...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A1623443&from=J-GLOBAL&jstjournalNo=W4673A") }}

Thesaurus term： freezing and solidification ,  plasma concentration ,  Thrombosis ,  *auricular fibrillation ,  Fibrinolysis ,  *Thrombin ,  *prothrombin ,  coloring (phenomenon) ,  ablation ,  biomarker ,  Factor Xa ,  Thromboembolism

Author keywords (4)： Prothrombin activation fragment 1 and 2 ,  Factor Xa (FXa) inhibitors ,  Atrial fibrillation ,  Monitoring

JST classification (2)： Clinical application of drugs acting on blood and body fluid  (GW14020X) ,  Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M)

Substance index (2)： Rivaroxaban ,  Apixaban

Terms in the title (10)： リバロキサバン ,  アピキサバン ,  投与 ,  心房細動 ,  患者 ,  プロトロンビン ,  活性化 ,  フラグメント ,  役割 ,  モニタリング